The non-invasive traumatic brain injury diagnostic equipment market size is expected to grow from US$ 1.349 billion in 2022 to US$ 3.541 billion by 2030.

Factors such as the accelerated demand for advanced diagnostic equipment and quick and effective diagnosis for TBI patients propel the non-invasive traumatic brain injury diagnostic equipment market growth. However, the adverse effects of contrast medium/agent impede the growth of the market.

Growth Drivers:

Quick and Effective Diagnosis for TBI Patients Drives Non-invasive Traumatic Brain Injury Diagnostic Equipment Market Growth

The main hurdle for the recovery of TBI is that it is often left undiagnosed or misdiagnosed. In the past, concussions and TBIs were diagnosed through diagnostic equipment such as computed tomography (CT) scans and other neurological examinations. However, the use of CT can increase the risk of cancer due to radiation exposure. Therefore, a prompt and accurate brain injury diagnosis is of utmost importance to address mild to severe brain injuries. In October 2023, the Biomedical Advanced Research and Development Authority (BARDA) announced a collaboration with GE Healthcare to develop a novel artificial intelligence (AI)-augmented ultrasound technology in order to promote rapid diagnosis of traumatic injuries. Also, BARDA will support GE Healthcare in developing a portable ultrasound system to enhance disaster preparedness with fast response for trauma care during mass casualty incidents. Therefore, technological advancements are expected to bring new non-invasive traumatic brain injury diagnostic equipment market trends in the coming years.

Emergence of Portable Nonivasive Monitoring Devices to Diagnose TBI Patients Acts as a Non-invasive Traumatic Brain Injury Diagnostic Equipment Future Trend

New non-invasive methods for monitoring tissue metabolism can help improve the diagnosis and monitoring of brain conditions such as concussions, stroke, and TBI, owing to which patients can recover more quickly. The consequences of TBI resulted in increasing healthcare burden costs, accounting for US$ 76.5 billion annually, as per the BrainScope company white paper. Installing "BrainScope One" in less expensive care settings-e.g., emergency department and community settings (including urgent care centers)-may significantly reduce healthcare costs by up to 32.2%, as per the findings revealed in the white paper. BrainScope One aids in eliminating unnecessary CT scans, thereby reducing healthcare costs for TBI. Thus, advancements in diagnosis and monitoring of brain conditions discovery will likely bring new avenues for non-invasive traumatic brain injury diagnostic equipment market trends in the coming years.

Report Segmentation and Scope:

The "non-invasive traumatic brain injury diagnostic equipment market analysis" has been carried out by considering the following segments: technique, device type, and end user.

Non-invasive Traumatic Brain Injury Diagnostic Equipment Market, by Technique:

By technique, the non-invasive traumatic brain injury diagnostic equipment market is segmented into electroencephalography, eye tracking and near-infrared spectroscopy, magnetoencephalography, transcranial magnetic stimulation, cerebral metabolic rate of oxygen, magnetic resonance imaging, intracranial pressure, brain-computer interface, and others. The magnetic resonance imaging segment held the largest non-invasive traumatic brain injury diagnostic equipment market share in 2022. The eye tracking and near-infrared spectroscopy segment is anticipated to register the highest CAGR of 14.3% during the forecast period.

Non-invasive Traumatic Brain Injury Diagnostic Equipment Market, by Device Type:

By device type, the non-invasive traumatic brain injury diagnostic equipment market is divided into imaging devices and monitoring devices. The imaging devices segment held a larger non-invasive traumatic brain injury diagnostic equipment market share in 2022 and monitoring devices is anticipated to register a higher CAGR of 14.5% during the forecast period.

Non-invasive Traumatic Brain Injury Diagnostic Equipment Market, by End User:

By end user, the non-invasive traumatic brain injury diagnostic equipment market is categorized into hospitals & clinics, diagnostic centers, and others. The hospitals & clinics segment held the largest non-invasive traumatic brain injury diagnostic equipment market share in 2022 and diagnostic centers is anticipated to register the highest CAGR of 13.4% during the forecast period.

Strategic Developments:

The non-invasive traumatic brain injury diagnostic equipment market forecast can help stakeholders in this marketplace plan their growth strategies. A few strategic developments by leading players operating in the non-invasive traumatic brain injury diagnostic equipment market are listed below:

- In April 2022, Imeka announced a collaboration with GE Healthcare to expand the capabilities of magnetic resonance imaging (MRI) and advance precision medicine for brain health. GE will integrate Imeka's non-invasive neuroimaging technology into the BrainWave advanced diffusion processing, allowing researchers and clinicians to analyze injuries by MRI signals into the brain in great detail.

Competitive Landscape and Key Companies:

GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Natus Medical Inc, Raumedic AG, BrainScope Co Inc, Luciole Medical AG, Soterix Medical Inc, Medtronic Plc, Vivonics Inc, NanoDx Inc, Compumedics Ltd, Sense Diagnostics Inc, NeuraSignal Inc, and Neurovigil Inc are the prominent companies in the non-invasive traumatic brain injury diagnostic equipment market report. These companies focus on new technologies, upgrading existing products, and geographic expansions to meet the growing consumer demand worldwide. Sense Neuro Diagnostics announced clearance to conduct clinical trials for hemorrhage detection. The new trial approved by the FDA Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices began in June 2023, including up to 300 patients in 30 US, Canada, and Indian sites. This non-invasive technology has the potential to collect 360 data points within 2.5 seconds to detect brain hemorrhage or stroke type, thereby helping quick response by physicians, emergency department personnel, neuro ICU teams, and military field hospitals assessing and monitoring TBI. Furthermore, innovative product launches by US-based companies to improve diagnosis outcomes of patients suffering from TBI stimulate the non-invasive traumatic brain injury diagnostic equipment market growth.